mGluR5 Antagonist-Induced Psychoactive Properties: MTEP Drug Discrimination, a Pharmacologically Selective Non–NMDA Effect with Apparent Lack of Reinforcing Properties

@article{Swedberg2014mGluR5AP,
  title={mGluR5 Antagonist-Induced Psychoactive Properties: MTEP Drug Discrimination, a Pharmacologically Selective Non–NMDA Effect with Apparent Lack of Reinforcing Properties},
  author={Michael D B Swedberg and M. Ellgren and P. Raboisson},
  journal={The Journal of Pharmacology and Experimental Therapeutics},
  year={2014},
  volume={349},
  pages={155 - 164}
}
  • Michael D B Swedberg, M. Ellgren, P. Raboisson
  • Published 2014
  • Chemistry, Medicine
  • The Journal of Pharmacology and Experimental Therapeutics
  • Fenobam [N-(3-chlorophenyl)-N′-(4,5-dihydro-1-methyl-4-oxo-1H-imidazole-2-yl)urea], a potent metabotropic glutamate mGluR5 receptor antagonist, reported to have analgesic effects in animals and anxiolytic effects in humans, also caused adverse events, including psychostimulant-type effects and “derealization phenomena.” Recent electrophysiologic, pharmacologic, and anatomic data show that the mGluR5 antagonists 2-methyl-6-(phenylethynyl)pyridine (MPEP) and (E)-2-methyl-6-styryl-pyridine (SIB… CONTINUE READING
    11 Citations
    AZD9272 and AZD2066: Selective and Highly Central Nervous System Penetrant mGluR5 Antagonists Characterized by Their Discriminative Effects
    • 16
    • PDF
    Partial mGlu5 Negative Allosteric Modulators Attenuate Cocaine-Mediated Behaviors and Lack Psychotomimetic-Like Effects
    • 21
    • PDF
    Pharmacology of Basimglurant (RO4917523, RG7090), a Unique Metabotropic Glutamate Receptor 5 Negative Allosteric Modulator in Clinical Development for Depression
    • 61
    • PDF
    Recent insights into the mode of action of memantine and ketamine.
    • 54
    Kinetic and system bias as drivers of metabotropic glutamate receptor 5 allosteric modulator pharmacology
    • 7
    • Highly Influenced
    Drug discrimination: A versatile tool for characterization of CNS safety pharmacology and potential for drug abuse.
    • 6
    Emerging Trends in Pain Modulation by Metabotropic Glutamate Receptors
    • 21
    • PDF

    References

    SHOWING 1-10 OF 88 REFERENCES
    The Behavioral Profile of the Potent and Selective mGlu5 Receptor Antagonist 3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]pyridine (MTEP) in Rodent Models of Anxiety
    • 149
    • PDF
    Fenobam: A Clinically Validated Nonbenzodiazepine Anxiolytic Is a Potent, Selective, and Noncompetitive mGlu5 Receptor Antagonist with Inverse Agonist Activity
    • 273
    • Highly Influential
    • PDF
    mGluR5, but not mGluR1, antagonist modifies MK-801-induced locomotor activity and deficit of prepulse inhibition
    • 77
    • Highly Influential
    N-methyl-D-aspartate antagonism and phencyclidine-like activity: a drug discrimination analysis.
    • 65
    • Highly Influential
    mGluR5 antagonists 2-methyl-6-(phenylethynyl)-pyridine and (E)-2-methyl-6-(2-phenylethenyl)-pyridine reduce traumatic neuronal injury in vitro and in vivo by antagonizing N-methyl-D-aspartate receptors.
    • 115
    • Highly Influential
    2-Methyl-6-(phenylethynyl)-pyridine (MPEP), a potent, selective and systemically active mGlu5 receptor antagonist
    • 706